Researchers recently unveiled this novel antibody , a potential approach targeting a particular target involved in malignancy growth . Initial data suggest that Codrituzumab shows significant efficacy in animal studies, potentially providing a fresh avenue for individuals battling various forms of cancer . Further human studies are expected to eval